Showing results 3 to 6 of 6
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
2022 | |||
Vonoprazan-based dual and triple therapy versus bismuth-based quadruple therapy as first-line therapy for Helicobacter pylori in China: a three-arm, randomized clinical trial Proceeding/Conference:Digestive Disease Week 2024 (18/05/2024-21/05/2024, , , Washington, DC, USA) | 18-May-2024 | ||
Vonoprazan-based dual and triple therapy versus bismuth-based quadruple therapy as first-line therapy for Helicobacter pylori in China: a three-arm, randomized clinical trial Proceeding/Conference:United European Gastroenterology Week (12/10/2024-15/10/2024, Vienna) | 14-Oct-2024 | ||
1-Mar-2023 |